iVistaVida 2.4% is a premium Hydroxypropyl Methylcellulose (HPMC) ophthalmic solution specifically designed for intraocular use. This viscoelastic agent plays a vital role during ophthalmic surgeries, particularly cataract surgeries and intraocular lens implantations, by providing exceptional lubrication, protecting delicate ocular tissues, and maintaining anterior chamber depth. This ensures a clear surgical field and reduces trauma to ocular structures. Manufactured under stringent quality standards, iVistaVida 2.4% guarantees superior safety and efficacy. The sterile, ready-to-use syringe offers convenience and precision, making it a trusted choice for ophthalmic surgeons worldwide. Count on iVistaVida 2.4% to enhance surgical outcomes while minimizing potential complications associated with ocular procedures.

Key Features

Features	Description
Active Ingredient	Hydroxypropyl Methylcellulose (HPMC) 2.4% w/v
Volume	3ml
Formulation	Viscoelastic ophthalmic solution
Usage	For intraocular surgical procedures such as cataract surgery
Packaging	Sterile, ready-to-use syringe for ease of application
Safety Standards	Manufactured under stringent quality control with no impurities
Storage Conditions	Store at 2°C to 25°C, avoid freezing and direct sunlight

Attributes	Description
Indication	Intraocular use during ophthalmic procedures
Viscosity	Optimal viscosity regulates tissue stability
Biocompatibility	Compatible with ocular tissues
Sterility	Use immediately after opening to maintain sterility
Administration	To be administered by trained professionals only
Precautions	Do not use if packaging is damaged or if compatibility is uncertain

*Disclaimer: This above description has been AI generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.

Product Reviews

Be the first to write a review

Review this product

Your Rating*clear

Your Review*

Add an Image

Incorporation Type
GST
GST Registration Date
Number of Employees
Import Export Code (IEC)
Year of Establishment
Nature of Business
GlobalLinker Member Since

Brand: iVistaVida 2.4%

Country of Origin: India

iVistaVida 2.4% is a premium ophthalmic solution formulated with Hydroxypropyl Methylcellulose (HPMC) 2.4% w/v in a 3ml presentation. Designed specifically for intraocular use, it serves as a viscoelastic agent during ophthalmic procedures such as cataract surgeries and intraocular lens implantation.

This solution provides exceptional lubrication and tissue protection, ensuring clear visualization and reducing trauma to delicate ocular structures. It enhances the surgical field by maintaining space within the anterior chamber, stabilizing tissues, and minimizing damage caused by instrument manipulation.

Manufactured under stringent quality standards, iVistaVida 2.4% is free of impurities and contaminants, ensuring superior safety and efficacy. Its optimal viscosity and biocompatibility make it a trusted choice for ophthalmic surgeons worldwide.

Packaged in a sterile, ready-to-use syringe, iVistaVida 2.4% simplifies application while ensuring convenience and precision during surgical procedures.

Hydroxypropyl Methylcellulose Ophthalmic Solution USP 2.4% w/v (iVistaVida 2.4%) is an intraocular surgical aid primarily used during cataract surgery and other ophthalmic procedures. It helps to maintain anterior chamber depth, protects corneal endothelial cells, and stabilizes tissues during intraocular lens implantation.

Usage:

Administered only by trained professionals during surgery.

Provides a viscoelastic protective layer in the anterior chamber to facilitate surgical manipulation.

Storage Instructions:

Store at a temperature of 2°C to 25°C.

Avoid freezing or exposure to direct sunlight.

Use the product immediately after opening to maintain sterility.

Precautions:

For intraocular use only. Do not use if the packaging is damaged.

Discard unused portions after surgery.

Ensure compatibility with other surgical materials to avoid complications.

This product is meticulously designed to enhance surgical outcomes while minimizing potential trauma to ocular tissues.

IVistaVida 2.4%